Production (Stage)
CareRx Corporation
CRRX.TO
TSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 109.86% | -507.73% | 73.81% | -162.79% | 85.90% |
Total Depreciation and Amortization | 0.32% | -5.47% | -0.78% | -1.39% | 2.14% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -52.43% | 64.29% | -29.66% | 43.54% | -52.64% |
Change in Net Operating Assets | -93.37% | -78.28% | 714.84% | -72.62% | 36.18% |
Cash from Operations | -14.38% | -33.13% | 52.13% | -14.28% | 6.85% |
Capital Expenditure | 40.30% | -119.50% | -18.65% | -47.21% | 60.31% |
Sale of Property, Plant, and Equipment | -- | -80.33% | -82.49% | 511.11% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 79.56% | -25.77% | -14.78% | 23.84% | 11.94% |
Cash from Investing | 48.84% | -91.05% | -27.65% | -3.30% | 47.68% |
Total Debt Issued | -72.22% | -- | -- | -- | -- |
Total Debt Repaid | 40.96% | 39.04% | 0.67% | -122.00% | 96.31% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | 25.68% | -47.77% | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -1.64% | 6.37% | 55.71% | -1,673.49% | 92.34% |
Cash from Financing | 21.20% | 54.61% | 14.34% | -194.93% | 89.72% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 218.12% | -49.33% | 129.68% | -194.21% | 114.93% |